Compounds for the treatment of metabolic disorders

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 59/68 (2006.01) A61K 31/192 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2654530

3-(2,4-Bis(trifluoromethyl)benzyloxy)phenylacetic acid, 4-(2,6-Dimethylbenzyloxy)- phenylacetic acid, and their pharmaceutically acceptable salts are useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis.

La présente invention concerne l'acide 3-(2,4-bis(trifluorométhyl)benzyloxy)phénylacétique, l'acide 4-(2,6-diméthylbenzyloxy)phénylacétique, et leurs sels pharmaceutiquement acceptables. Ces composés se révèlent utiles pour le traitement de divers troubles métaboliques, tels que le syndrome d'insulino-résistance, le diabète, le syndrome des ovaires polykystiques, l'hyperlipidémie, la stéatose hépatique, la cachexie, l'obésité, l'athérosclérose et l'artériosclérose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of metabolic disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1546188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.